NC court requires chemical ID of fakes

Drug analysts at North Carolina's State Bureau of Investigation can no longer use visual inspection alone in drug cases. The process they had been using involved analyst identification of prescription drugs simply by looking at them. They'll be using chemical analysis from now on.

The state's Supreme Court mandated the change, calling the visual ID method a technique for cutting corners, according to a local press report. A judge said he had little faith in an experienced analyst's ability to make consistently correct identifications. The analyst had selected half of a drug haul in one case for chemical analysis and used a pharmacy handbook for identification of the others, which he identified as Hydrocodone, Adderall, Xanax, Diazepam and Ritalin.

Some states allow visual-inspection methods, which have been affirmed by higher courts. Two states, however, have blocked the practice.

In North Carolina, lawyers predict appeals of convictions in drug counterfeiting and trafficking cases. One suggests there are "potentially tens of thousands" of such cases.

- see the story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.